Gilead Sciences, Inc.

$83.88 -0.02%
NASDAQ: GILD
Market Cap.: 104.4 B XL
P/E: 102.29 x34.52
EPS: 0.82 x 4.40
Earnings Call
1 month, 2 weeks from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield: 1.09%
Payout: -23.74%
Volume Level
μ 7,032,698
846,417 Moderate Low
Performance Ranks (Intraday)
United States:

1777th

out of

2160

Healthcare:

602nd

out of

792

Drug Manufacturers—General:

45th

out of

62

Peer Group:

5th

out of

8

About

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, …